Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A B Wark

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
The European Respiratory Journal|February 21, 2002
Neutrophil degranulation and cell lysis is associated with clinical severity in virus-induced asthmaP A B Wark, S L Johnston, I Moric, et al.
The European Respiratory Journal|September 17, 2011
Soluble RAGE is deficient in neutrophilic asthma and COPDM B Sukkar, L G Wood, M Tooze, et al.
Internal Medicine Journal|June 29, 2016
Effectiveness and response predictors of omalizumab in a severe allergic asthma population with a high prevalence of comorbidities: the Australian Xolair RegistryP G Gibson, H Reddel, V M McDonald, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|April 21, 2018
Working while unwell: Workplace impairment in people with severe asthmaS A Hiles, E S Harvey, V M McDonald, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
The European Respiratory Journal|February 21, 2002
Neutrophil degranulation and cell lysis is associated with clinical severity in virus-induced asthmaP A B Wark, S L Johnston, I Moric, et al.
The European Respiratory Journal|September 17, 2011
Soluble RAGE is deficient in neutrophilic asthma and COPDM B Sukkar, L G Wood, M Tooze, et al.
Internal Medicine Journal|June 29, 2016
Effectiveness and response predictors of omalizumab in a severe allergic asthma population with a high prevalence of comorbidities: the Australian Xolair RegistryP G Gibson, H Reddel, V M McDonald, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|April 21, 2018
Working while unwell: Workplace impairment in people with severe asthmaS A Hiles, E S Harvey, V M McDonald, et al.
Pageof 2